PetMed Express (NASDAQ:PETS – Get Free Report) issued its earnings results on Monday. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.02), RTT News reports. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%.
PetMed Express Stock Performance
Shares of PetMed Express stock opened at $5.27 on Tuesday. The company has a fifty day simple moving average of $5.13 and a 200-day simple moving average of $4.31. PetMed Express has a 12-month low of $2.90 and a 12-month high of $6.85.
Analyst Ratings Changes
Separately, StockNews.com upgraded shares of PetMed Express from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th.
Insider Activity
In other PetMed Express news, Director Leslie C.G. Campbell purchased 15,000 shares of PetMed Express stock in a transaction that occurred on Wednesday, December 4th. The stock was purchased at an average price of $5.38 per share, for a total transaction of $80,700.00. Following the transaction, the director now directly owns 70,000 shares in the company, valued at $376,600. This trade represents a 27.27 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.10% of the company’s stock.
About PetMed Express
PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Further Reading
- Five stocks we like better than PetMed Express
- The 3 Best Retail Stocks to Shop for in August
- Monday.com Stock Could Soar to New Highs—Here’s How
- What is the Hang Seng index?
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.
